- decreased body weight / IMPC
- fused cornea and lens / IMPC
- abnormal cornea morphology / IMPC
- corneal opacity / IMPC
- abnormal coat/hair pigmentation / IMPC
- decreased lean body mass / IMPC
- improved glucose tolerance / IMPC
- increased circulating amylase level / IMPC
- decreased total body fat amount / IMPC
- decreased circulating fructosamine level / IMPC
- increased circulating magnesium level / IMPC
- decreased bone mineral content / IMPC
- preweaning lethality, complete penetrance / IMPC
B6Dnk;B6Brd;B6N-Tyrc-Brd Pfn1tm1a(EUCOMM)Wtsi/WtsiBiat
Status | Available to order |
EMMA ID | EM:06990 |
International strain name | B6Dnk;B6Brd;B6N-Tyrc-Brd Pfn1tm1a(EUCOMM)Wtsi/WtsiBiat |
Alternative name | EPD0046_1_C10 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Pfn1tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Pfn1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0046_1_C10. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | University of Veterinary Medicine, Vienna, Austria |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Amyotrophic lateral sclerosis / Orphanet_803
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- abnormal cornea morphology / IMPC
- fused cornea and lens / IMPC
- increased circulating amylase level / IMPC
- improved glucose tolerance / IMPC
- decreased bone mineral content / IMPC
- corneal opacity / IMPC
- abnormal coat/hair pigmentation / IMPC
- decreased body weight / IMPC
- increased circulating magnesium level / IMPC
- decreased circulating fructosamine level / IMPC
- decreased total body fat amount / IMPC
- preweaning lethality, complete penetrance / IMPC
- decreased lean body mass / IMPC
MGI phenotypes (gene matching)
- decreased body weight / MGI
- no abnormal phenotype detected / MGI
- decreased total body fat amount / MGI
- decreased circulating fructosamine level / MGI
- decreased bone mineral content / MGI
- perinatal lethality, incomplete penetrance / MGI
- embryonic lethality before implantation, complete penetrance / MGI
- prenatal lethality, incomplete penetrance / MGI
- lethality, complete penetrance / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).